INTRODUCTION
Histiocytic sarcoma is a rare neoplasm characterized by the malignant proliferation of cells that have the morphologic and immunophenotypic features of mature tissue histiocytes [1] . It is an aggressive neoplasm with poor prognosis, and the mechanism underlying its pathogenesis is still unknown [1] . Characteristic features of this sarcoma include the appearance of a solitary mass with systemic manifestations such as fever and weight loss.
Histiocytic sarcoma can be diagnosed on the basis of the morphological features of the histiocytic lineage and by excluding the possibility of lymphoma and other poorly differentiated large-cell malignancies [2] . The diagnosis is confirmed if the biopsy results are positive for more than one immunophenotypic marker for mature histiocytic cells (e.g., CD68, lysozyme, CD11c, and CD14) and negative for myeloid markers (e.g., myeloperoxidase, CD33, and CD34), accessory/dendritic cell markers (CD1a, CD21, and CD35), CD30, HMB-45, epithelial membrane antigen, or keratin [1] . Histiocytic sarcomas usually occur in the intestinal tract, skin, and soft tissues [1] ; therefore, diagnosis of these sarcomas by bone marrow biopsy has rarely been reported. We report a case of histiocytic sarcoma diagnosed by bone marrow biopsy just before the patient' s death. 
282
Histiocytic sarcoma is a malignant proliferation of cells showing morphologic and immunophenotypic features similar to those of mature tissue histiocytes and is known for its rapid progression and poor prognosis. We describe a case of histiocytic sarcoma diagnosed by bone marrow biopsy. A 64-yr-old male was admitted for fever and weight loss that persisted for 8 months. The patient died undiagnosed on the 7th hospitalization day. A bone marrow biopsy performed just before the patient's death revealed diffuse proliferation of large pleomorphic neoplastic cells with large, round to oval nuclei, vesicular chromatin, and abundant foamy cytoplasm. These cells were positive for histiocytic markers, CD68, lysozyme, CD21, and S-100 protein, but negative for B-cell, T/NK-cell, and epithelial cell markers, thus confirming the presence of histiocytic sarcoma. (Fig. 1) accessory/dendritic cell markers [1, 3] . Pileri et al. [3] recommended immunostaining for CD68, lysozyme, CD1a, S100
protein, CD21, and CD35 for the differential diagnosis of histiocytic and accessory dendritic cell neoplasms. CD163, a hemoglobin scavenger receptor, has been suggested as a novel diagnostic marker for histiocytic malignancies [4] .
In our case, the bone marrow of the patient was infiltrated with proliferating large pleomorphic neoplastic cells CD68 + + + + + Lysozyme T  CD13  NT  NT  NT  NT  -CD30  NT  NT  --NT  CD31  +  NT  +  NT  NT  CD34  NT  NT  -NT  -LCA  NT  NT  +  +  NT  CD45RO  NT  NT  +  NT  -CD56  --NT  NT  NT  CD99  +  NT  NT  NT  NT  CD117  NT  NT  -NT  NT  CD138  NT  -NT  NT  NT  S100 protein  +  ---+  Desmin  NT  NT  -NT  NT  Vimentin  +  NT  NT  NT  NT  Cytokeratin  --NT  NT  NT  HMB45  -NT  NT  -NT  SMMHC  -NT  NT  NT  NT  SMA  -NT  -NT  NT  EMA NT -NT -NT that had large, round to oval nuclei, vesicular chromatin, and abundant foamy cytoplasm. These cells were positive for histiocytic markers, CD68, lysozyme, CD21, and S-100
protein, but negative for B-cell, T/NK-cell, and epithelial cell markers. Therefore, we could confirm the diagnosis of histiocytic sarcoma by excluding the possibility of lymphoma, carcinoma, and melanoma.
Histiocytic sarcoma occurs in individuals across a wide age range; it is mostly found in adults (median age, 46 yr) with a predilection for males [5] . In the majority of the cases, it occurs in extranodal sites, most commonly the intestinal tract, skin, and soft tissues [1] . The cause or pathophysiology is still unknown, except, possibly, when mediastinal germ cell tumors are the precursor lesions [3, 6] .
In Korea, several cases of histiocytic sarcoma were reported. Two cases were diagnosed on the basis of a solitary mass in the rectum [7] and spleen [8] . In one case, the diagnosis was based on the results of bone marrow biopsy [9] . Their immunohistochemical profiles showed the presence of macrophage/histiocyte markers and the absence of myeloid and lymphoid markers ( Table 1 ).
The prognosis of histiocytic sarcoma is poor [5] . Most patients (60-80%) expire due to progressive disease, because they are diagnosed too late [3, 4] . However, some patients with small, localized primary tumors have a more favorable long-term outcome [3] . Some patients have shown more than 10 yr of disease-free survival [10] . With regard to cases in Korea, a patient with histiocytic sarcoma presented with a 2-cm rectal mass and survived for 32 months without relapse [7] . A patient with a multinodular splenic mass showed 15 months of disease-free survival [8] . In contrast, a patient with disseminated histiocytic sarcoma diagnosed by bone marrow biopsy, died only 5 months after diagnosis [9] .
In our case, a PET scan of the 64-yr-old male patient showed multiple high-density lesions in the bone, intestine, skin, and soft tissue. However, there was no evidence of malignant histiocytic proliferation in the bone, softtissue, lymph-node, and liver biopsies. The patient suffered from FUO and weight loss for 8 months. Performing diagnostic tests for FUO 3 times did not help determine the cause of the fever. He showed no response to empirical anti-tuberculosis medication and dexamethasone therapy and died from respiratory failure. The diagnosis was made posthumously on the basis of a bone marrow biopsy taken just before his death.
Understanding this exceedingly rare malignancy is highly important in order to diagnose and treat the patient in time.
